Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Lee, Chin Cheng ^a,b,c   Lai, Jin Huei ^d   Hueng, Dueng Yang ^d   Ma, Hsin I ^d   Chung, Yuan C ^e   Sun, Ya yun ^f   Tsai, Yih Ju ^f   Wu, Wen Ben ^f   Chen, Chih Li ^f  

^a Shin Kong Memorial Hospital   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c YUANPEI UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e CHENG CHING GENERAL HOSPITAL   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; CXCL12; CXCR4; Glioblastoma stem like cell (GSC); Invasiveness

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; METHYLCELLULOSE; SHORT HAIRPIN RNA; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CELL RENEWAL; COLONY FORMATION; CONTROLLED STUDY; DNA CONTENT; FLOW CYTOMETRY; GLIOBLASTOMA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

EID: 84882351009     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-85     Document Type: Article

References (49)

1. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007, 21(21):2683-2710. 10.1101/gad.1596707, 17974913.
2. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008, 359(5):492-507. 10.1056/NEJMra0708126, 18669428.
3. Neethan A, Lobo YS, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007, 23:675-699. 10.1146/annurev.cellbio.22.010305.104154, 17645413.
4. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401. 10.1038/nature03128, 15549107.
5. Ping YF, Bian XW. Consice review: contribution of cancer stem cells to neovascularization. Stem cells (Dayton, Ohio) 2011, 29(6):888-894.
6. Altaner C, Altanerova V. Stem cell based glioblastoma gene therapy. Neoplasma 2012, 59(6):756-760. 10.4149/neo_2012_95, 22862177.
7. Molina JR, Hayashi Y, Stephens C, Georgescu MM. Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia (New York, NY) 2010, 12(6):453-463.
8. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Del Bo R, Fortunato F, Strazzer S, Salani S, Bresolin N, Comi GP. Multipotentiality, homing properties, and pyramidal neurogenesis of CNS-derived LeX(ssea-1)+/CXCR4+ stem cells. FASEB J 2005, 19(13):1860-1862.
9. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY, Khoury SJ. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004, 101(52):18117-18122. 10.1073/pnas.0408258102, 536055, 15608062.
10. Zlotnik A. Chemokines in neoplastic progression. Semin Cancer Biol 2004, 14(3):181-185. 10.1016/j.semcancer.2003.10.004, 15246053.
11. Bian XW, Yang SX, Chen JH, Ping YF, Zhou XD, Wang QL, Jiang XF, Gong W, Xiao HL, Du LL, Chen ZQ, Zhao W, Shi JQ, Wang JM. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurgery 2007, 61(3):570-578. discussion 578-579, 10.1227/01.NEU.0000290905.53685.A2, 17881971.
12. Moneeb Ehtesham XY, Nancy HC, Chung Gentao L, Yasuharu A, Keith L, Black KL, Yu JS. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia (New York, NY) 2004, 6:287-293.
13. Ehtesham M, Mapara KY, Stevenson CB, Thompson RC. CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett 2009, 274(2):305-312. 10.1016/j.canlet.2008.09.034, 2628453, 19008040.
14. Barth RF, Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 2009, 94(3):299-312. 10.1007/s11060-009-9875-7, 2730996, 19381449.
15. Ferrier MC, Sarin H, Fung SH, Schatlo B, Pluta RM, Gupta SN, Choyke PL, Oldfield EH, Thomasson D, Butman JA. Neoplasia (New York, NY) 2007, 9(7):546-555.
16. Zagorac D, Jakovcevic D, Gebremedhin D, Harder DR. Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 2008, 28(8):1431-1439.
17. Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC, Jiang T, Lin MC, Chen JH, Wang B, Zhang R, Cui YH, Qian C, Wang JM, Bian XW. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J Pathol 2011, 224(3):344-354. 10.1002/path.2908, 21618540.
18. Busillo JM, Benovic JL. Regulation of CXCR4 signaling. Biochim Biophys Acta 2007, 1768(4):952-963. 10.1016/j.bbamem.2006.11.002, 1952230, 17169327.
19. Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, Jeon JW, Kim MH, Kang BG, Jung Y, Jin J, Hong SC, Park WY, Lee DS, Kim H, Nam DH. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 2008, 88(8):808-815. 10.1038/labinvest.2008.57, 18560366.
20. Lottaz C, Beier D, Meyer K, Kumar P, Hermann A, Schwarz J, Junker M, Oefner PJ, Bogdahn U, Wischhusen J, Spang R, Storch A, Beier CP. Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res 2010, 70(5):2030-2040. 10.1158/0008-5472.CAN-09-1707, 20145155.
21. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008, 40(5):499-507. 10.1038/ng.127, 2912221, 18443585.
22. Zbinden M, Duquet A, Lorente-Trigos A, Ngwabyt SN, Borges I, Ruiz i Altaba A. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 2010, 29(15):2659-2674. 10.1038/emboj.2010.137, 2928692, 20581802.
23. Hagerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, Ostman A, Nister M. Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile. Neuro Oncol 2011, 13(11):1178-1191. 10.1093/neuonc/nor113, 3199157, 21940738.
24. Nakano I, Paucar AA, Bajpai R, Dougherty JD, Zewail A, Kelly TK, Kim KJ, Ou J, Groszer M, Imura T, Freije WA, Nelson SF, Sofroniew MV, Wu H, Liu X, Terskikh AV, Geschwind DH, Kornblum HI. Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. J Cell Biol 2005, 170:413-427. 10.1083/jcb.200412115, 2171475, 16061694.
25. Strojnik T, Rosland GV, Sakariassen PO, Kavalar R, Lah T. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 2007, 68(2):133-143. discussion 143-134, 10.1016/j.surneu.2006.10.050, 17537489.
26. Malcolm JM, Darkes GLPBJ. Temozolomide, a review of its Use in the treatment of malignant gliomas, malignant melanoma and other advanced cancers. Am J Cancer 2002, 1(1):55-80.
27. Redjal N, Chan JA, Segal RA, Kung AL. CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clinical cancer research: an official journal of the American Association for Cancer Research 2006, 12(22):6765-6771.
28. Silber JR, Bobola MS, Blank A, Chamberlain MC. O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems. Biochim Biophys Acta 2012, 1826(1):71-82. 3340514, 22244911.
29. Zagzag D, Lukyanov Y, Lan L, Ali MA, Esencay M, Mendez O, Yee H, Voura EB, Newcomb EW. Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 2006, 86(12):1221-1232. 10.1038/labinvest.3700482, 17075581.
30. Harris ES, Nelson WJ. VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol 2010, 22(5):651-658. 10.1016/j.ceb.2010.07.006, 2948582, 20708398.
31. Paulis YW, Soetekouw PM, Verheul HM, Tjan-Heijnen VC, Griffioen AW. Signalling pathways in vasculogenic mimicry. Biochimica et biophysica acta 2010, 1806(1):18-28.
32. Rong Y, Durden DL, Van Meir EG, Brat DJ. 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 2006, 65(6):529-539. 10.1097/00005072-200606000-00001, 16783163.
33. Rojiani MV, Alidina J, Esposito N, Rojiani AM. Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp Pathol 2010, 3(8):775-781. 2993228, 21151391.
34. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13(3):206-220. 10.1016/j.ccr.2008.01.034, 2643426, 18328425.
35. Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, Wappler I, Peters H, Walter T, Stojkovic P, Evans J, Stojkovic M, Lako M. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 2006, 15(11):1894-1913. 10.1093/hmg/ddl112, 16644866.
36. Caldera V, Mellai M, Annovazzi L, Monzeglio O, Piazzi A, Schiffer D. MGMT hypermethylation and MDR system in glioblastoma cancer stem cells. Cancer Genomics Proteomics 2012, 9(4):171-178.
37. Zhang J, Stevens MF, Bradshaw TD. Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol 2012, 5(1):102-114.
38. Hardee ME, Zagzag D. Mechanisms of Glioma-Associated Neovascularization. Am J Pathol 2012, 181(4):1126-1141. 10.1016/j.ajpath.2012.06.030, 22858156.
39. Huang Z, Cheng L, Guryanova OA, Wu Q, Bao S. Cancer stem cells in glioblastoma-molecular signaling and therapeutic targeting. Protein Cell 2010, 1(7):638-655. 10.1007/s13238-010-0078-y, 21203936.
40. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, Gilbertson RJ. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11(1):69-82. 10.1016/j.ccr.2006.11.020, 17222791.
41. Rao S, Sengupta R, Choe EJ, Woerner BM, Jackson E, Sun T, Leonard J, Piwnica-Worms D, Rubin JB. CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma. PloS One 2012, 7(3):e33005. 10.1371/journal.pone.0033005, 3299723, 22427929.
42. Farin A, Suzuki SO, Weiker M, Goldman JE, Bruce JN, Canoll P. Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 2006, 53(8):799-808. 10.1002/glia.20334, 16541395.
43. El Hallani S, Boisselier B, Peglion F, Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL, Eichmann A, Delattre JY, Maniotis AJ, Sanson M. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain: a journal of neurology 2010, 133(Pt 4):973-982.
44. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria I.R. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 68(7325):824-828.
45. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology (Baltimore, Md) 2009, 50(5):1464-1474.
46. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995, 36(2):169-180. 10.1007/BF00666038, 8534865.
47. Lee CC, Jan HJ, Lai JH, Ma HI, Hueng DY, Lee YC, Cheng YY, Liu LW, Wei HW, Lee HM. Nodal promotes growth and invasion in human gliomas. Oncogene 2010, 29(21):3110-3123. 10.1038/onc.2010.55, 20383200.
48. Booth BW, Boulanger CA, Anderson LH, Jimenez-Rojo L, Brisken C, Smith GH. Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res 2010, 316(3):422-432. 10.1016/j.yexcr.2009.11.006, 2812656, 19913532.
49. Hong X, Chedid K, Kalkanis SN. Glioblastoma cell line-derived spheres in serumcontaining medium versus serum-free medium: a comparison of cancer stem cell properties. Int J Oncol 2012, 41(5):1693-700.